{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:03:41Z","timestamp":1792904621464,"version":"4.5.0"},"reference-count":145,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Innovation fonden","award":["4289-00312B"],"award-info":[{"award-number":["4289-00312B"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Inflammatory bowel disease (IBD) is a global disease with a considerable increase in prevalence and the impact on the health and well-being of patients suffering from this condition is vast. Diet has been suspected of being a contributor to IBD severity as well as intake of antibiotics. Methods: A literary search was conducted on the most recent studies on the subject of IBD, diet, and medical treatment to identify high-quality research findings within this area of research. Research published within the last decade was prioritized. Studies in English language were included in the search, and the knowledge gained was synthesized in the review. Results: Dietary patterns, specifically intake of Westernized diets, were associated with increased inflammation and increased disease severity in patients suffering from IBD, specifically patients suffering from Crohn\u2019s disease (CD). A co-administration of pre- and probiotics was found to contribute to disease remission in ulcerative colitis patients, however, to a lesser extent in patients with CD. A bidirectional effect on the intestinal microbiome was seen as a result of intake of the medicines used for the treatment of IBD patients, which affects both bioavailability of the drug and efficacy of the treatment. The baseline composition of the intestinal microbiome in IBD patients dictates their response to the different treatments. Conclusions: Diet and medical treatment both have a large impact on the architecture of the intestinal Microbiome in IBD patients and are, as such, both essential to understand to enable individualized and optimized treatment.<\/jats:p>","DOI":"10.3390\/nu18010009","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:59:57Z","timestamp":1766149197000},"page":"9","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gut Microbiota in IBD: The Beneficial and Adverse Effects of Diet and Medication"],"prefix":"10.3390","volume":"18","author":[{"given":"Aidan Eric","family":"Juhl","sequence":"first","affiliation":[{"name":"Department of Bioengineering, Florida Gulf Coast University, Fort Myers, FL 33965, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Westfall","sequence":"additional","affiliation":[{"name":"Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, 5000 Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4247-5920","authenticated-orcid":false,"given":"Betina","family":"Hebbelstrup Jensen","sequence":"additional","affiliation":[{"name":"Center for General Practice, Department of Public Health, University of Copenhagen, 1353 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengameh Chlo\u00e9","family":"Mirsepasi-Lauridsen","sequence":"additional","affiliation":[{"name":"Center for General Practice, Department of Public Health, University of Copenhagen, 1353 Copenhagen, Denmark"},{"name":"Department of Gastroenterology, Copenhagen University Hospital Hvidovre, 2650 Hvidovre, Denmark"},{"name":"Department of Infectious Diseases, Copenhagen University Hospital Hvidovre, 2650 Hvidovre, Denmark"},{"name":"Department of Research and Development, 1Health Gut Inn Balance, 2680 Solroed Strand, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e00060-18","DOI":"10.1128\/CMR.00060-18","article-title":"Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease","volume":"32","author":"Vallance","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/S0399-8320(09)73159-8","article-title":"Nutritional consequences and nutrition therapy in Crohn\u2019s disease","volume":"33","author":"Filippi","year":"2009","journal-title":"Gastroent\u00e9rologie Clin. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clnu.2025.02.019","article-title":"The dietary inflammatory potential and its role in the risk and progression of inflammatory bowel disease: A systematic review","volume":"47","author":"Anneberg","year":"2025","journal-title":"Clin. Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1847976","DOI":"10.1080\/19490976.2020.1847976","article-title":"Ulcerative Colitis-associated E. coli pathobionts potentiate colitis in susceptible hosts","volume":"12","author":"Yang","year":"2020","journal-title":"Gut Microbes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e13412","DOI":"10.1111\/sji.13412","article-title":"Dysregulation of T cell response in the pathogenesis of inflammatory bowel disease","volume":"100","author":"Chandwaskar","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"ref_6","first-page":"704","article-title":"Update on the incidence and prevalence of inflammatory bowel disease in the United States","volume":"12","author":"Loftus","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ecco-jcc\/jjad155","article-title":"The Incidence and Prevalence of Inflammatory Bowel Disease Continues to Increase in the Faroe Islands\u2014A Cohort Study from 1960 to 2020","volume":"18","author":"Nielsen","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1210\/er.2018-00280","article-title":"The Gut Microbiome Influences Host Endocrine Functions","volume":"40","author":"Rastelli","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MCG.0000000000001676","article-title":"Association between Sex Hormone Levels and Gut Microbiota Composition and Diversity\u2014A Systematic Review","volume":"56","author":"Upadhyaya","year":"2022","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MPG.0000000000003861","article-title":"Early Life Oral Antibiotics Are Associated With Pediatric-Onset Inflammatory Bowel Disease\u2014A Nationwide Study","volume":"77","author":"Jawad","year":"2023","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"Molecular and Cellular Endocrinology The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.3748\/wjg.v13.i42.5560","article-title":"Novel genetic markers in inflammatory bowel disease","volume":"13","author":"Fonseca","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Statovci, D., Aguilera, M., MacSharry, J., and Melgar, S. (2017). The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00838"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Leach, S.T. (2024). Role of Probiotics and Prebiotics in Gut Symbiosis. Nutrients, 16.","DOI":"10.3390\/nu16020238"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105905","DOI":"10.1016\/j.isci.2022.105905","article-title":"Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH","volume":"26","author":"Kang","year":"2023","journal-title":"iScience"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/apt.12372","article-title":"Systematic review: Body composition in adults with inflammatory bowel disease","volume":"38","author":"Bryant","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000495214","article-title":"A multicentre study of nutrition risk assessment in adult patient","volume":"74","author":"Lomer","year":"2019","journal-title":"Ann. Nutr. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clnu.2016.01.005","article-title":"Resting energy expenditure in adult patients with Crohn\u2019 s disease","volume":"36","author":"Sammarco","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Narula, N., Dhillon, A., Zhang, D., Me, S., Tondeur, M., and Zachos, M. (2018). Enteral nutritional therapy for induction of remission in Crohn\u2019s disease. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD000542.pub3"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.07.050","article-title":"A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn\u2019s Disease and Ulcerative Colitis","volume":"145","author":"Ananthakrishnan","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/gutjnl-2022-328174","article-title":"Lifestyle Factors for the Prevention of Inflammatory Bowel Disease","volume":"72","author":"Lopes","year":"2023","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1136\/gutjnl-2011-301574","article-title":"Geographical variation and incidence of inflammatory bowel disease among US women","volume":"61","author":"Khalili","year":"2012","journal-title":"Gut"},{"key":"ref_23","first-page":"749","article-title":"Evolution of Mediterranean diets and cuisine: Concepts and definitions","volume":"26","author":"Grad","year":"2017","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/gutjnl-2019-319505","article-title":"Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn\u2019s disease: Results from two large prospective cohort studies","volume":"69","author":"Khalili","year":"2020","journal-title":"Gut"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/ecco-jcc\/jjad073","article-title":"A Mediterranean Diet Pattern Improves Intestinal Inflammation Concomitant with Reshaping of the Bacteriome in Ulcerative Colitis: A Randomised Controlled Trial","volume":"17","author":"Haskey","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.psychres.2007.06.001","article-title":"Patterns of stress in schizophrenia","volume":"160","author":"Betensky","year":"2008","journal-title":"Psychiatry Res."},{"key":"ref_27","first-page":"873","article-title":"Dietary Inflammatory Potential and Risk of Crohn\u2019s Disease and Ulcerative Colitis","volume":"159","author":"Potential","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.2003.024828","article-title":"Influence of dietary factors on the clinical course of ulcerative colitis: A prospective cohort study","volume":"53","author":"Jowett","year":"2004","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.3748\/wjg.v20.i33.11505","article-title":"Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease","volume":"20","author":"Orel","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2125.2008.03096.x","article-title":"Probiotics and prebiotics in inflammatory bowel disease: Microflora \u201con the scope\u201d","volume":"65","author":"Damaskos","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/MIB.0000000000000084","article-title":"Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: A meta-analysis","volume":"20","author":"Mardini","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mirsepasi-Lauridsen, H.C. (2022). Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease. J. Clin. Med., 11.","DOI":"10.3390\/jcm11247472"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.3748\/wjg.v12.i37.5978","article-title":"Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells","volume":"12","author":"Helwig","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_35","first-page":"36","article-title":"Introduction and overview: Recent advances in the immunotherapy of inflammatory bowel disease","volume":"38","author":"Hibi","year":"2003","journal-title":"J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1172\/JCI119823","article-title":"Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease","volume":"100","author":"Hogaboam","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_37","first-page":"e00624-21","article-title":"A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917","volume":"6","author":"Chagneau","year":"2021","journal-title":"Am. Soc. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.crohns.2014.06.001","article-title":"Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial","volume":"8","author":"Petersen","year":"2014","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2036.1997.00225.x","article-title":"Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis","volume":"11","author":"Kruis","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","article-title":"Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial","volume":"354","author":"Rembacken","year":"1999","journal-title":"Lancet"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.cgh.2009.07.016","article-title":"The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis","volume":"7","author":"Sood","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ajg.2010.218","article-title":"Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: A double-blind, randomized, placebo-controlled study","volume":"105","author":"Tursi","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_44","first-page":"41","article-title":"Antimicrobial and immunomodulatory activity of some probiotic fractions with potential clinical application","volume":"11","author":"Iordache","year":"2008","journal-title":"Zootechnica"},{"key":"ref_45","first-page":"G10","article-title":"Incrimination of anaerobic bacteria in the induction of experimental colitis","volume":"272","author":"Antolin","year":"1997","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Nielsen","year":"2013","journal-title":"Nature"},{"key":"ref_47","first-page":"73","article-title":"Bifidobacteria and Their Health-Promoting Effects","volume":"5","author":"Delgado","year":"2017","journal-title":"Gut"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1128\/AEM.00928-06","article-title":"Inactivation of adhesion and invasion of food-borne Listeria monocytogenes by bacteriocin-producing Bifidobacterium strains of human origin","volume":"72","author":"Moroni","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Vakadaris, G., Stefanis, C., Giorgi, E., Brouvalis, M., Voidarou, C., Kourkoutas, Y., Tsigalou, C., and Bezirtzoglou, E. (2023). The Role of Probiotics in Inducing and Maintaining Remission in Crohn\u2019 s Disease and Ulcerative Colitis: A Systematic Review of the Literature. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020494"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"100027","DOI":"10.1016\/j.medmic.2020.100027","article-title":"Fecal microbiota transplantation: Uses, questions, and ethics","volume":"6","author":"Grigoryan","year":"2021","journal-title":"Med. Microecol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/CCM.0000000000002382","article-title":"Fecal micobiota transplantation to treat sepsis of unclear etiology","volume":"45","author":"Gaines","year":"2017","journal-title":"Crit. Care Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/00365521.2021.1922749","article-title":"Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation FMT","volume":"56","author":"Baunwall","year":"2021","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10096-019-03615-x","article-title":"Establishing a donor stool bank for faecal microbiota transplantation: Methods and feasibility","volume":"38","author":"Rode","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect Dis."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Svensson, C.K., Cold, F., Ribberholt, I., Zangenberg, M., Mirsepasi-Lauridsen, H.C., Petersen, A.M., and Helms, M. (2022). The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study. Cells, 11.","DOI":"10.3390\/cells11203272"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/apt.14173","article-title":"Systematic review with meta-analysis: Faecal microbiota transplantation for the induction of remission for active ulcerative colitis","volume":"46","author":"Costello","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/gutjnl-2018-316434","article-title":"Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: Results from a randomised, double-blind placebo-controlled study","volume":"67","author":"Christensen","year":"2018","journal-title":"Gut"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pourrat, A., Baillieu, V., Ansel, S., Leonardi, M., Poiron, P., Bellais, S., Paul, M., and Nebbad, B. (2025). Standardized freeze-dried FMT: Is the ideal protectant out there?. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1618067"},{"key":"ref_59","unstructured":"(2024, July 17). Official Journal of the European Union, REGULATION (EU) 2024\/1938 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 13 June 2024 on Standards of Quality and Safety for Substances of Human Origin Intended for Human Application and Repealing Directives 2002\/98\/EC and 2004\/23\/EC, EN L Series, 17.7. Available online: https:\/\/eur-lex.europa.eu\/eli\/reg\/2024\/1938\/oj."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.18103\/mra.v12i5.5462","article-title":"Fecal Microbiota Transplantation promotes disease remission in a patient with active Crohn\u2019s disease: A Case Report","volume":"12","author":"Lauridse","year":"2024","journal-title":"Med. Res. Arch."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ecco-jcc\/jjz060","article-title":"Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients with Ulcerative Colitis: A Pilot Study","volume":"13","author":"Sood","year":"2019","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_64","unstructured":"Lauridsen, H.C. (2021). Capsule Comprising a Faecal Composition. (WO2021130182A1)."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gibaldi, M., and Perrier, D. (1982). Pharmacokinetics, Routledge. [2nd ed.].","DOI":"10.1201\/b14095"},{"key":"ref_66","first-page":"1","article-title":"Guidance for Industry Bioavailability and Bioequivalence Guidance for Industry Bioavailability and Bioequivalence","volume":"2014","author":"Considerations","year":"2014","journal-title":"Biopharmaceutics"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11882-013-0404-6","article-title":"Role of \u201cWestern Diet\u201d in Inflammatory Autoimmune Diseases","volume":"14","author":"Manzel","year":"2015","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_68","first-page":"968","article-title":"Ultra-Processed Profits: The Political Economy of Countering the Global Spread of Ultra-Processed Foods\u2014A Synthesis Review on the Market and Political Practices of Transnational Food Corporations and Strategic Public Health Responses","volume":"10","author":"Moodie","year":"2021","journal-title":"Int. J. Health Policy Manag."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.cgh.2023.01.012","article-title":"Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"21","author":"Narula","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Yang, F., Xie, R., Huang, M., Hu, C., Wu, Y., Li, X., and Chen, H. (2025). High-Fat Diet-Induced Mild Obesity Alters the Activation of T Cells and Maintains Intestinal Homeostasis in Food Allergy Animal Model. Foods, 14.","DOI":"10.3390\/foods14111852"},{"key":"ref_71","first-page":"459","article-title":"State of the art paper High dietary salt intake activates inflammatory cascades via Th17 immune cells: Impact on health and diseases","volume":"18","author":"Balan","year":"2022","journal-title":"Arch. Med. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1038\/srep04768","article-title":"Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease","volume":"4","author":"Nowak","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/am.17.1.83-87.1969","article-title":"Volatile fatty acids and the inhibition of Escherichia coli growth by rumen fluid","volume":"17","author":"Wolin","year":"1969","journal-title":"Appl. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/BF01536987","article-title":"Organic anions and the diarrhea of inflammatory bowel disease","volume":"33","author":"Vernia","year":"1988","journal-title":"Dig. Dis. Sci."},{"key":"ref_76","first-page":"507","article-title":"Digestion and absorption of fiber carbohydrate in the colon","volume":"81","author":"Fleming","year":"1986","journal-title":"Am. J. Gastroenterol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.47.3.397","article-title":"Butyrate inhibits inflammatory responses through NF B inhibition: Implications for Crohn\u2019 s disease","volume":"47","author":"Segain","year":"2000","journal-title":"Gut"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0148607107031004311","article-title":"Nutrition assessment of patients with inflammatory bowel disease","volume":"31","author":"Vagianos","year":"2007","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12263-007-0012-y","article-title":"Uncoupling gene\u2014Diet interactions in inflammatory bowel disease (IBD)","volume":"2","author":"Ferguson","year":"2007","journal-title":"Genes Nutr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1083\/jcb.200102028","article-title":"Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling","volume":"154","author":"Espada","year":"2001","journal-title":"J. Cell Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-2478(93)90088-J","article-title":"1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro","volume":"35","author":"Bendtzen","year":"1993","journal-title":"Immunol. Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1074\/jbc.C109.071225","article-title":"Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2\/CARD15-defensin \u03b22 innate immune pathway defective in crohn disease","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cgh.2006.03.010","article-title":"Polymeric Diet AloneVersus Corticosteroids in the Treatment of Active Pediatric Crohn\u2019s Disease: A Randomized Controlled Open-Label Trial","volume":"4","author":"Borrelli","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2018.09.004","article-title":"Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer","volume":"175","author":"Singh","year":"2018","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature14232","article-title":"Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome","volume":"519","author":"Chassaing","year":"2015","journal-title":"Nature"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"Review The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Parada Venegas, D., De la Fuente, M.K., Landskron, G., Gonz\u00e1lez, M.J., Quera, R., Dijkstra, G., Harmsen, H.J.M., Faber, K.N., and Hermoso, M.A. (2019). Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00277"},{"key":"ref_88","first-page":"19032","article-title":"Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation","volume":"6","author":"Agus","year":"2018","journal-title":"Nat. Publ. Gr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10\u2212\/\u2212mice","volume":"487","author":"Devkota","year":"2013","journal-title":"Nature"},{"key":"ref_90","first-page":"462","article-title":"Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis","volume":"26","author":"Khan","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/gutjnl-2012-304119","article-title":"Western diet induces dysbiosis with increased e coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation","volume":"63","author":"Denizot","year":"2014","journal-title":"Gut"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/ajg.2010.192","article-title":"Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study","volume":"105","author":"Jantchou","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"ref_94","first-page":"469","article-title":"Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance","volume":"1851","author":"Calder","year":"2015","journal-title":"Biochim. Et Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_95","first-page":"1351","article-title":"IBD: In Food We Trust","volume":"2016","author":"Savoye","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jnutbio.2013.05.001","article-title":"Benefits of polyphenols on gut microbiota and implications in human health","volume":"24","author":"Cardona","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9517","DOI":"10.1021\/jf402506c","article-title":"Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition","volume":"9","author":"Etxeberria","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature13793","article-title":"Artificial sweeteners induce glucose intolerance by altering the gut microbiota","volume":"514","author":"Suez","year":"2014","journal-title":"Nature"},{"key":"ref_99","first-page":"531","article-title":"Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials","volume":"10","author":"Gil","year":"2019","journal-title":"Adv. Nutr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/2050640618780762","article-title":"Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis","volume":"6","author":"Ianiro","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/apt.14203","article-title":"Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease","volume":"46","author":"Derwa","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00228-023-03534-z","article-title":"Proton pump inhibitor use: Systematic review of global trends and practices","volume":"79","author":"Shanika","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.cmi.2015.10.003","article-title":"The Influence of Nonsteroidal Anti-Inflammatory Drugs on the Gut Microbiome Mary","volume":"22","author":"Rogers","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"558924","DOI":"10.3389\/fphar.2020.01153","article-title":"NSAID\u2013Gut Microbiota Interactions","volume":"11","author":"Maseda","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/MIB.0000000000000332","article-title":"Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases","volume":"21","author":"Huang","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ibd\/izad126","article-title":"Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition\u2014A Prospective Multicenter Study","volume":"30","author":"Blesl","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_109","first-page":"6147124","article-title":"Exploring Different Effects of Exclusive Enteral Nutrition (EEN) and Corticosteroids on the Gut Microbiome in Crohn \u2019 s Disease Based on a Three-Stage Strategy","volume":"2022","author":"Guo","year":"2022","journal-title":"Gastroenterol. Res. Pr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5223\/pghn.2023.26.3.165","article-title":"Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn \u2019 s Disease: The Patient Perspective","volume":"26","author":"Brown","year":"2023","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12967-022-03569-3","article-title":"Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis","volume":"20","author":"Huang","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Li, W., Shu, Y., Zhang, J., Wu, M., Zhu, G.-H., Huang, W.-Y., Shen, L., and Kang, Y. (2023). Long-term prednisone treatment causes fungal microbiota dysbiosis and alters the ecological interaction between gut mycobiome and bacteriome in rats. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1112767"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1053\/j.gastro.2006.01.048","article-title":"American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease","volume":"130","author":"Oppenheimer","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: Relationship to daily and cumulative doses","volume":"39","author":"Leufkens","year":"2000","journal-title":"Rheumatology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","article-title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: A nested case\u2014Control analysis","volume":"71","author":"Dixon","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4065\/81.10.1361","article-title":"Psychiatric Adverse Effects of Corticosteroids","volume":"81","author":"Thomas","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","article-title":"Corticosteroids and risk of gastrointestinal bleeding: A systematic review and meta-analysis","volume":"4","author":"Narum","year":"2014","journal-title":"BMJ Open"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Asadullah","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1210\/clinem\/dgae250","article-title":"European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency","volume":"109","author":"Beuschlein","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"12241","DOI":"10.1038\/s41598-023-39491-x","article-title":"5-Aminosalicylic acid alters the gut microbiota and altered microbiota transmitted vertically to offspring have protective effects against colitis","volume":"13","author":"Wada","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ajg.2011.67","article-title":"Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e02120-17","DOI":"10.1128\/mBio.02120-17","article-title":"Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn\u2019s Disease Patients","volume":"9","author":"Doherty","year":"2018","journal-title":"mBio"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","article-title":"Gut microbiome function predicts response to anti-integrin biologic therapy in Inflammatory Bowel diseases","volume":"21","author":"Ananthakrishnan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"127660","DOI":"10.1016\/j.micres.2024.127660","article-title":"Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review","volume":"282","author":"Wang","year":"2024","journal-title":"Microbiol. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2019.07.025","article-title":"Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases","volume":"157","author":"Aden","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"103329","DOI":"10.1016\/j.ebiom.2021.103329","article-title":"Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers","volume":"66","author":"Cui","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Veltkamp, S.H.C., and Voorneveld, P.W. (2025). The Cell-Specific Effects of JAK1 Inhibitors in Ulcerative Colitis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14020608"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s10787-025-01723-z","article-title":"Comparative efficacy of pharmacologic interventions in ulcerative colitis: A network meta analysis","volume":"33","author":"Khan","year":"2025","journal-title":"Inflammopharmacology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"107365","DOI":"10.1016\/j.ejps.2025.107365","article-title":"European Journal of Pharmaceutical Sciences Assessing the effects of tofacitinib on the gut microbiome in inflammatory bowel disease","volume":"216","author":"Favaron","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Bravo, G.\u00c1., Cede\u00f1o, R.R., Casadevall, M.P., and Rami\u00f3-Torrent\u00e0, L. (2022). Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives. Cells, 11.","DOI":"10.3390\/cells11132058"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1235656","DOI":"10.3389\/fphys.2023.1235656","article-title":"The role of sphingosine-1-phosphate in the gut mucosal microenvironment and in fl ammatory bowel diseases","volume":"14","author":"Zou","year":"2023","journal-title":"Front. Physiol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Choon, X.Y., Yeo, J.H., White, C., Sharma, E., and Samaan, M.A. (2025). The Current Sphingosine 1 Phosphate Receptor Modulators in the Management of Ulcerative Colitis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14103475"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/tp.2018.11.02","article-title":"Antibiotics in inflammatory bowel diseases: Do we know what we\u2019 re doing?","volume":"8","author":"Ledder","year":"2019","journal-title":"Transl. Pediatr."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gut.2010.219683","article-title":"Antibiotic use and inflammatory bowel diseases in childhood","volume":"60","author":"Hviid","year":"2011","journal-title":"Gut"},{"key":"ref_135","first-page":"343","article-title":"Natural history of the infant gut microbiome and impact of antibiotic treatments on strain-level diversity and stability","volume":"8","author":"Yassour","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/ecco-jcc\/jjad096","article-title":"Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease","volume":"17","author":"Sabino","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2016.04.003","article-title":"Antibiotic-Induced Changes in the Intestinal Microbiota and Disease","volume":"22","author":"Becattini","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cgh.2024.02.010","article-title":"Antibiotic Exposure and Risk of New-Onset Inflammatory Bowel Disease: A Systematic Review and Dose-Response","volume":"23","author":"Duan","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/gutjnl-2022-327845","article-title":"Antibiotic use as a risk factor for inflammatory bowel disease across the ages: A population-based cohort study","volume":"72","author":"Faye","year":"2023","journal-title":"Gut"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1493991","DOI":"10.3389\/fimmu.2024.1493991","article-title":"Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways","volume":"15","author":"Taitz","year":"2025","journal-title":"Front. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Nishida","year":"2018","journal-title":"Clin. J. Gastroenterol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.3748\/wjg.v22.i21.5050","article-title":"Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity","volume":"22","author":"Moller","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/gutjnl-2020-321798","article-title":"Inflammatory bowel diseases among first-generation and second-generation immigrants in Denmark: A population-based cohort study","volume":"70","author":"Agrawal","year":"2021","journal-title":"Gut"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s40750-017-0061-4","article-title":"Breaking Bread: The Functions of Social Eating","volume":"3","author":"Dunbar","year":"2017","journal-title":"Adapt. Hum. Behav. Physiol."},{"key":"ref_145","first-page":"4","article-title":"Antibiotic Exposure and IBD Development Among Children: A Population-Based Cohort Study","volume":"77","author":"Theoklis","year":"2012","journal-title":"Pediatrics"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/1\/9\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:02:46Z","timestamp":1766149366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/1\/9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":145,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["nu18010009"],"URL":"https:\/\/doi.org\/10.3390\/nu18010009","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]}}}